Cargando…
IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetes
Autores principales: | Narayanan, Ram P, Fu, Bo, Heald, Adrian H, Siddals, Kirk W, Oliver, Robert L, Hudson, Julie E, Payton, Antony, Anderson, Simon G, White, Anne, Ollier, William E R, Gibson, J Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioScientifica
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680963/ http://dx.doi.org/10.1530/EC-12-0053e |
Ejemplares similares
-
IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetes
por: Narayanan, Ram P, et al.
Publicado: (2012) -
A Longitudinal Clinical Trajectory Analysis Examining the Accumulation of Co-morbidity in People with Type 2 Diabetes (T2D) Compared with Non-T2D Individuals
por: Heald, Adrian, et al.
Publicado: (2023) -
Erratum to: Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting
por: Huang, Xiu-yan, et al.
Publicado: (2016) -
Male hypogonadism: 14‐year prospective outcome in 550 men with type 2 diabetes
por: Malipatil, Nagaraj S., et al.
Publicado: (2019) -
Erratum: Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells
por: Tochigi, Hideno, et al.
Publicado: (2017)